Another seven states cover one or more weight loss drugs but not any GLP-1s
It must be at least 48 hours
Recent moves Cost containment: Incremental layoffs across 2024 and 205 Like Elevance Health, Humana executed layoffs across 2024 and 2025 that impacted multiple business segments across multiple states
Novos advertisements promoting its semaglutide product Wegovy could be another indicator of sufficient supply, according to Bayside, a poster in online investor forums including Hims House, a community that includes owners of the companys stock who identifies themself as a healthcare lobbyist and successfully predicted the resolution of the tirzepatide shortage
Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1
References: Cani PD et al., 2019 Written by Ali Rza Akn Microbiome Scientist, Author & Founder of Next-Microbiome Ali Rza Akn is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation
